Establishment of Correlation of Ki-67 Proliferative Index Expression in the Peritumoral Tissue with Tumor Mass in ER (Estrogen Receptor) Positive Breast Carcinoma
. Sukanya, Pratibha Dawande, Arvind Bhake, Sunita Vagha
Journal of Pharmaceutical Research International · pp. 24–33 · Published 28 Dec 2021
10.9734/jpri/2021/v33i61B35141Abstract
Background: Breast carcinoma is the second most frequently occurring malignant tumor. It usually arises in a multistep fashion from intermediary lesions to invasive cancer. Identifying such predominantly occurring lesions adjacent to malignancy and studying of Proliferative Ki-67 index and (ER) status in such lesions and substantiate their possible identity as a premalignant lesion. The study tries to establish the lesions which have the potential for progression to overt malignancy, thereby indicating early identification and appropriate treatment. Aim: To establish a correlation in the expression of Ki-67 proliferative index in the peritumoral tissue with tumor mass of ER-positive breast carcinomas. Objectives: 1.To study the expression of ER in breast tumor mass. 2. To study expression of Ki-67 proliferative index in breast tumor mass and peritumoral tissue. 3. To assess the expression of Ki-67 proliferative index in breast tumor mass and peritumoral tissue. Study design: Observational prospective study. Materials and Methods: 32 mastectomy specimens of diagnosed cases of breast carcinoma sent to the Histopathology Section are studied. Gross features are described and the histopathological section stained by (H & E) stain and immunohistochemistry using monoclonal antibody to (ER) and proliferation-associated antigen (Ki-67) are studied. Statistics: Chi-square test, Spearman’s rank-order correlation coefficient, and software used in the analysis were SPSS 22.0 version and Graph Pad Prism 6.0 version and p<0.05 is considered as the level of significance. Results: In this study out of 32 ER-positive cases, 24 showed positivity for Ki-67 in tumor mass and 22 cases showed high Ki-67 in peritumoral tissue. Maximum lesions were proliferative lesions with atypia like ADH and DCIS. Conclusion: Ki-67 is an accurate nuclear proliferative marker to assess cell proliferation status. In breast carcinoma adjacent peritumoral lesions show a high proliferative index which suggests a link and a trail of generation of premalignant lesions converting to invasive carcinoma. Proliferative lesions with and without atypia, moderate epithelioid, atypical ductal hyperplasia, and DCIS more or else equals IDC for Ki-67 proliferative index. Such cases should be regularly followed up for progression of these lesions to malignancy.
Cited by 0
No indexed citations yet.
Related research
- Placenta Development and Ki-67 Nuclear Immunolocalization in Placental Tissues of the Wild Type and Domesticated Silver Fox (Vulpes fulvus Desm.) — shares topic coverage
- P53 and Ki67 Expression by Cervical Cancers in Ile-Ife, Nigeria — shares topic coverage
- The Potential Role of Ki-67 Index in the Prognosis of Breast Cancer and Its Relation to Molecular Subtypes in Egyptian Females with Breast Cancer — shares topic coverage
- Histopathological Alterations and Ki-67 Proliferation Index Evaluation Following Nitroso Bis Amine-Induced Cerebral Toxicity in Experimental Animal Model Treated with Curcumin — shares topic coverage
- Precision Frontiers in Mantle Cell Lymphoma: Tailored Therapies and Emerging Innovations — shares topic coverage
Article metrics
Real usage data collected on this platform.
29
Page views
0
PDF downloads
2
Outbound clicks
0
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.